ILAR category | Disease activity, active/inactive | HAQ Score* | JADI-A Score* | JADI-E Score* | Patients retired due to JIA (%) |
---|---|---|---|---|---|
P. oligoarthritis | 34/22 (n=56) | 0.26±0.4 (n=79) | 0.8±1.4 (n=26) | 0.2±0.7 (n=19) | 1 (2.9) (n=34) |
E. oligoarthritis | 39/10 (n=49) | 0.58±0.8 (n=61) | 7.6±15 (n=22) | 0.7±1.3 (n=18) | 8 (25.8) (n=31) |
RF+ polyarthritis | 36/14 (n=50) | 0.80±0.7 (n=71) | 18.3±17.6 (n=13) | 0.7±1.4 (n=9) | 11 (22) (n=50) |
RF− polyarthritis | 39/19 (n=58) | 0.61±0.7 (n=75) | 9.6±15.2 (n=33) | 1.3±2.3 (n=28) | 6 (13.6) (n=44) |
SoJIA | 20/12 (n=32) | 0.43±0.6 (n=41) | 13±21.8 (n=13) | 1.2±1.9 (n=9) | 0 (n=15) |
ERA | 28/18 (n=46) | 0.45±0.7 (n=80) | 5.5±12.2 (n=31) | 0.7±1.2 (n=26) | 3 (6.3) (n=48) |
PsA | 5/4 (n=9) | 0.40±0.4 (n=13) | 0±0 (n=2) | 0±0 (n=2) | 1 (16.6) (n=6) |
Undif. arthritis | n=0 | 0.69±0.2 (n=6) | n=0 | n=0 | 1 (16.6) (n=6) |
*Values are mean±SD.
E. oligoarthritis, extended oligoarthritis; ERA, enthesitis-related arthritis; HAQ, Health Assessment Questionnaire; ILAR, International League of Associations for Rheumatology; JADI, Juvenile Arthritis Damage Index; JIA, juvenile idiopathic arthritis; P. oligoarthritis, persistent oligoarthritis; PsA, psoriatic arthritis; RF+ polyarthritis, rheumatoid factor negative polyarthritis; RF+ polyarthritis, rheumatoid factor positive polyarthritis; SoJIA, systemic onset juvenile idiopathic arthritis; Undif. arthritis, undifferentiated arthritis.